Matthias Holdhoff, MD

Matthias Holdhoff, MD is a renowned medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. Dr. Holdhoff specializes in primary brain cancers and central nervous system lymphomas, with a focus on translational research and clinical trials in neuro-oncology.

His extensive education includes a medical degree from Freie Universität Berlin and residency training in internal medicine at Johns Hopkins Bayview Medical Center. Dr. Holdhoff completed a fellowship in medical oncology at Johns Hopkins Hospital, with research training at the Ludwig Center for Cancer Genetics and Therapeutics.

As a clinical investigator, Dr. Holdhoff leads multiple brain cancer trials and contributes to publications and presentations in the field of neuro-oncology. He is actively involved in mentoring and teaching fellows, residents, and students, and serves as a teaching attending physician for the Osler internal medicine residency program.

Dr. Holdhoff's research focuses on novel biomarkers for assessing response and disease activity in malignant gliomas and primary central nervous system lymphomas. His dedication to advancing treatments for brain cancer is evident in his leadership in early phase therapeutic clinical trials and translational research projects.

Patients at Matthias Holdhoff, MD can expect expert care and personalized treatment for brain cancer and brain tumors, with a strong emphasis on cutting-edge research and clinical trials. Although masks are strongly recommended at the institution, they are not required in accordance with Maryland guidelines. Despite potential delays due to the recent collapse of the Francis Scott Key Bridge, patients can trust in the exceptional care provided by Dr. Holdhoff and his team at this esteemed institution in Baltimore, Maryland.